PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515485
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515485
Asia Pacific Theranostics Market, By Product Type, By Application, By End-User, By Country - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Asia Pacific Theranostics Market size was valued at USD 493.40 million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032
Theranostics, an integration of precisely targeted therapies and specialized diagnostics, represents an emerging domain within the realm of drug discovery. Its primary objective is to facilitate the early detection and treatment of both primary tumors and metastases. The various methodologies explored in this study elucidate recent advancements in their application and underscore their substantial potential for further research and development. By employing theranostics, they move one step closer to utilizing the mentioned carriers as a preferred approach for delivering active substances, specifically targeting the treatment site while also monitoring the treatment's efficacy. This theranostics strategy offers numerous significant advantages over conventional non-targeted chemotherapy drugs.
Asia Pacific Theranostics Market- Market Dynamics
The prevalence of chronic diseases like cancer, cardiovascular diseases, and neurological disorders is expected to drive the growth of the market
The Asia Pacific region exhibits some of the highest cancer rates globally, especially in nations such as China, Japan, and India. This prevalence underscores the need for advanced diagnostic and therapeutic solutions. Personalized cancer treatment, facilitated by theranostics, is pivotal in identifying the most suitable therapies based on individual tumor characteristics, ultimately improving patient outcomes and minimizing side effects. Recent epidemiological data reveals that China alone sees over 2.2 million new cancer cases annually, with 1.4 million in men and 0.8 million in women, resulting in approximately 1.6 million cancer-related deaths. Moreover, the expansion of healthcare infrastructure in developing economies is creating new market opportunities, although limited awareness and expertise may impede market growth.
Asia Pacific Theranostics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)
Based on Product Type segmentation, Diagnostic Imaging was predicted to show maximum market share in the year 2023
Based on Application segmentation, Prostate Cancer was the leading type in 2023
Based on End-User segmentation, Hospitals, and Cancer Care Centers were the leading type in 2023
Based on countries, China was the leading revenue generator in 2023
Asia Pacific Theranostics Market- Segmentation Analysis:
The Asia Pacific Theranostics Market is segmented based on Product Type, Application, End-User, and Country.
The market is categorized into three segments according to the type of product: Diagnostic Imaging, Radiopharmaceuticals, and In-vitro diagnostics (IVD)/biomarkers screening, along with Software and services. The dominant segment in the market is Diagnostic Imaging. This particular approach customizes therapies for each patient by utilizing diagnostic tests, thereby improving the effectiveness of treatments and the overall outcomes for patients.
The market is segmented into three categories according to Application: Prostate Cancer, Neuroendocrine Cancer, Adult Pheochromocytoma, and other conditions. Prostate Cancer holds the largest share of the market. Theranostics is essential in the treatment of prostate cancer in the Asia Pacific region, combining diagnostic and therapeutic methods to enhance patient results.
The market is segmented into five categories according to End-User: Hospitals and Cancer Care Centers, Theranostics Centers, and Research and Academic Centers. The dominant players in the market are Hospitals and Cancer Care Centers. These establishments are progressively embracing personalized medicine strategies, with theranostics playing a vital role in aligning patients with the most suitable treatments based on their genetic and molecular characteristics.
Asia Pacific Theranostics Market- Geographical Insights
The analysis of this market encompasses various countries such as India, China, South Korea, Japan, Australia, Thailand, Indonesia, and the Philippines, as well as the rest of the Asia Pacific (APAC) region. Among these, China stands out with the largest market share in theranostics, primarily due to its increasing focus on the development of innovative companion diagnostic tests. Chinese companies and research institutions are leading the way in the creation of these diagnostic tests, which play a vital role in the successful implementation of theranostics.
Asia Pacific Theranostics Market- Competitive Landscape:
The theranostics market in the Asia Pacific region is experiencing notable progress, especially in the domains of hospitals and cancer care. Theranostics entails the integration of diagnostics and targeted therapy, enabling the provision of personalized treatment approaches tailored to individual patients. Prominent hospitals and cancer centers throughout the Asia Pacific region are incorporating theranostics into their oncology departments to enhance treatment accuracy and improve patient outcomes. Both global pharmaceutical companies and local biotech firms are actively participating in the Asia Pacific theranostics market, striving to develop innovative solutions and establish partnerships to expand their presence in the region.
Recent Developments:
On December 2, 2021, Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company focused on developing advanced products to meet the increasing demands in oncology, and Cardinal Health reached a mutually beneficial agreement regarding Clarity's Targeted Copper Theranostics (TCT) platform.
On March 20, 2024, Bayer AG and Thermo Fisher Scientific Inc. disclosed a partnership aimed at creating advanced next-generation sequencing (NGS)-based companion diagnostic assays (CDx). The objective is to pinpoint individuals who could potentially gain from Bayer's expanding range of precise cancer treatments through the provision of decentralized genomic testing and swift results.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
ASIA PACIFIC THERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Bayer AG
GE Healthcare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cardinal Health, Inc.
Canon, Inc.
Clarity Pharmaceuticals Ltd
Koninklijke Philips N.V.
Thermo Fisher Scientific, Inc.
Telix Pharmaceuticals Limited
ABX Advanced Biochemical Compounds GmbH
Others
ASIA PACIFIC THERANOSTICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032
Diagnostic Imaging
Radiopharmaceuticals
In-vitro diagnostics (IVD)/biomarkers Screening
Software and services
ASIA PACIFIC THERANOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Prostate Cancer
Neuroendocrine Cancer
Adult Pheochromocytoma
Others
ASIA PACIFIC THERANOSTICS MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032
Hospitals and Cancer Care Centers
Theranostics Centers
Research and Academic Centers
ASIA PACIFIC THERANOSTICS MARKET, BY COUNTRY- MARKET ANALYSIS, 2019 - 2032
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Table of Contents
1. Asia Pacific Theranostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Asia Pacific Theranostics Market Snippet by Product Type
- 2.1.2. Asia Pacific Theranostics Market Snippet by Application
- 2.1.3. Asia Pacific Theranostics Market Snippet by End-User
- 2.1.4. Asia Pacific Theranostics Market Snippet by Country
- 2.2. Competitive Insights
3. Asia Pacific Theranostics Key Market Trends
- 3.1. Asia Pacific Theranostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Asia Pacific Theranostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Asia Pacific Theranostics Market Opportunities
- 3.4. Asia Pacific Theranostics Market Future Trends
4. Asia Pacific Theranostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Asia Pacific Theranostics Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Asia Pacific Theranostics Market Landscape
- 6.1. Asia Pacific Theranostics Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Asia Pacific Theranostics Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. Diagnostic Imaging
- 7.1.3. Radiopharmaceuticals
- 7.1.4. In-vitro diagnostics (IVD)/biomarkers Screening
- 7.1.5. Software and services
8. Asia Pacific Theranostics Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Prostate Cancer
- 8.1.3. Neuroendocrine Cancer
- 8.1.4. Adult Pheochromocytoma
- 8.1.5. Others
9. Asia Pacific Theranostics Market - By End-User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospitals and Cancer Care Centers
- 9.1.3. Theranostics Centers
- 9.1.4. Research and Academic Centers
10. Asia Pacific Theranostics Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. Asia Pacific (APAC)
- 10.2.1. Overview
- 10.2.2. Asia Pacific Theranostics Key Manufacturers in Asia Pacific
- 10.2.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. India
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. China
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.9. Japan
- 10.2.9.1. Overview
- 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.10. South Korea
- 10.2.10.1. Overview
- 10.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.11. Australia
- 10.2.11.1. Overview
- 10.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.12. Thailand
- 10.2.12.1. Overview
- 10.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.13. Indonesia
- 10.2.13.1. Overview
- 10.2.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.14. Philippines
- 10.2.14.1. Overview
- 10.2.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.15. Rest of APAC
- 10.2.15.1. Overview
- 10.2.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Asia Pacific Theranostics Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Bayer AG
- 11.2.2. GE HealthCare Technologies, Inc.
- 11.2.3. Siemens Healthineers AG (Siemens AG)
- 11.2.4. Cardinal Health, Inc.
- 11.2.5. Canon, Inc.
- 11.2.6. Clarity Pharmaceuticals Ltd
- 11.2.7. Koninklijke Philips N.V.
- 11.2.8. Thermo Fisher Scientific, Inc.
- 11.2.9. Telix Pharmaceuticals Limited
- 11.2.10. ABX advanced biochemical compounds GmbH
- 11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Asia Pacific Theranostics Market: Product Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product Type
- TABLE Asia Pacific Theranostics Market, by Product Type 2019-2032 (USD Million)
- TABLE Asia Pacific Theranostics Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Asia Pacific Theranostics Market, by Application 2019-2032 (USD Million)
- TABLE Asia Pacific Theranostics Market: End-User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Asia Pacific Theranostics Market, by End-User 2019-2032 (USD Million)
- TABLE Asia Pacific Asia Pacific Theranostics Market, by Country, 2019-2032 (USD Million)
List of Figures
- FIGURE Asia Pacific Theranostics Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Product Type segment market share analysis, 2023 & 2032
- FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Application segment market share analysis, 2023 & 2032
- FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE End-User segment market share analysis, 2023 & 2032
- FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Asia Pacific Theranostics Market share and leading players, 2023
- FIGURE Asia Pacific Asia Pacific Theranostics Market share analysis by country, 2023
- FIGURE India Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Asia Pacific Theranostics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
